HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection
0301 basic medicine
570
Cytoplasm
Infectious disease and host defense
Immunology
610
Innate immunity and inflammation
Herpesvirus 1, Human
Protein Serine-Threonine Kinases
Article
03 medical and health sciences
Animals
Humans
11 Medical and Health Sciences
Cells, Cultured
Deubiquitinating Enzymes
Ubiquitin
Lysine
Ubiquitination
Brain
Membrane Proteins
Nucleotidyltransferases
3. Good health
Mice, Inbred C57BL
HEK293 Cells
DNA, Viral
Interferon Type I
Mutation
Microglia
Signal Transduction
DOI:
10.1084/jem.20191422
Publication Date:
2020-05-08T13:24:01Z
AUTHORS (16)
ABSTRACT
Herpes simplex virus (HSV) is the main cause of viral encephalitis in the Western world, and the type I interferon (IFN) system is important for antiviral control in the brain. Here, we have compared Ifnb induction in mixed murine brain cell cultures by a panel of HSV1 mutants, each devoid of one mechanism to counteract the IFN-stimulating cGAS–STING pathway. We found that a mutant lacking the deubiquitinase (DUB) activity of the VP1-2 protein induced particularly strong expression of Ifnb and IFN-stimulated genes. HSV1 ΔDUB also induced elevated IFN expression in murine and human microglia and exhibited reduced viral replication in the brain. This was associated with increased ubiquitination of STING and elevated phosphorylation of STING, TBK1, and IRF3. VP1-2 associated directly with STING, leading to its deubiquitination. Recruitment of VP1-2 to STING was dependent on K150 of STING, which was ubiquitinated by TRIM32. Thus, the DUB activity of HSV1 VP1-2 is a major viral immune-evasion mechanism in the brain.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (61)
CITATIONS (74)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....